| Value | ₹21.31 Cr |
|---|---|
| Execution period | 5 years |
BSE filing, NSE: MPHASIS. Summary written from the filing by ALFA Finder's alert engine.
Mphasis Ltd: key numbers
- Share price
- ₹2,518.00
- Market cap
- ₹47,861 Cr
- Revenue (annual)
- ₹15,880 Cr
- Net profit (annual)
- ₹1,863 Cr
- P/E (TTM)
- 25.1×Sector 22.9×
- Promoter holding
- 30.53%-0.01% QoQ
- FII holding
- 19.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mphasis Ltd
All →Mphasis Other Announcement
Mphasis received SBTi validation of its near-term and net-zero emissions targets. The company targets net-zero GHG by FY 2050 with 66% Scope 1+2 cuts by FY 2036.
Mphasis Legal & Regulatory
Mphasis reported a revised income tax demand of ₹2,417.80 crore following a rectification order, up from the previously disclosed ₹2,286.86 crore.
- Value
- ₹2,418 Cr
Mphasis Other Announcement
Mphasis Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per SEBI Regulation 31(1)(b) requirements.
Mphasis Earnings Call Transcript: Key Takeaways
Management focused on AI integration and cost optimization amid a sluggish macro environment that led to a 6.5% constant currency revenue decline in FY24.
Mphasis Employee Stock Options
Mphasis granted 3,25,460 ESOPs at ₹2,300 and 1,63,040 RSUs at ₹10 to employees under 2026 plans. The grant strengthens long-term employee retention and alignment.
Mphasis Capital Structure Change
Kotak Mahindra Mutual Fund sold 1,23,216 shares of Mphasis Ltd, reducing its stake from 7.3015% to 7.237%. This sale was executed via open market.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date